15-79314004-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_007364.4(TMED3):āc.416A>Gā(p.Gln139Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007364.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMED3 | NM_007364.4 | c.416A>G | p.Gln139Arg | missense_variant, splice_region_variant | 2/3 | ENST00000299705.10 | NP_031390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMED3 | ENST00000299705.10 | c.416A>G | p.Gln139Arg | missense_variant, splice_region_variant | 2/3 | 1 | NM_007364.4 | ENSP00000299705.5 | ||
TMED3 | ENST00000424155.6 | c.416A>G | p.Gln139Arg | missense_variant, splice_region_variant | 2/3 | 3 | ENSP00000414983.2 | |||
TMED3 | ENST00000536821.5 | c.416A>G | p.Gln139Arg | missense_variant, splice_region_variant | 2/3 | 2 | ENSP00000446062.1 | |||
TMED3 | ENST00000543455.1 | n.416A>G | splice_region_variant, non_coding_transcript_exon_variant | 2/4 | 2 | ENSP00000440228.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251332Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135858
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461848Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727228
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.416A>G (p.Q139R) alteration is located in exon 2 (coding exon 2) of the TMED3 gene. This alteration results from a A to G substitution at nucleotide position 416, causing the glutamine (Q) at amino acid position 139 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at